Amenorrhea from breast cancer therapy - Not a matter of dose

New England Journal of Medicine

Volumn 363, Issue 23, 2010, Pages 2268-2270

  Swain, Sandra M ^a   Jeong, Jong Hyeon ^b   Wolmark, Norman ^c  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; ESTROGEN RECEPTOR;

ADJUVANT THERAPY; AMENORRHEA; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RELAPSE; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; DISEASE FREE SURVIVAL; DOSE RESPONSE; DRUG DOSE SEQUENCE; EARLY CANCER; FOLLOW UP; HAZARD RATIO; HUMAN; KAPLAN MEIER METHOD; LETTER; LYMPH NODE METASTASIS; MENSTRUAL IRREGULARITY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PREMENOPAUSE; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 78649729006     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1009616     Document Type: Letter

References (1)

1. Swain SM, Jeong J-H, Geyer CE Jr, et al. Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer. N Engl J Med 2010;362:2053-65.